Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-16 | New | $336,833 | $336,833 | Equity Only | 06b | SEC link |
| 2022-12-30 | New | $12,223,338 | $12,223,338 | Equity Only | 06b | SEC link |
| 2021-02-17 | New | $4,999,994 | $4,999,994 | Equity Only | 06b | SEC link |
| 2020-10-22 | New | $6,344,990 | $6,344,990 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jared Bearss | Director |
| David Bearss | Director, Executive |
| Jeffrey Burton | Executive |
| John S.K. Kauwe | Director |
| Mike Mc Cullar | Director, Executive |
| Mike Mccullar | Director, Executive |
| Todd Pedersen | Director |
| Gary B. Sabin | Director |
| Jim Savas | Director |